Volume | 1,321,643 |
|
|||||
News | - | ||||||
Day High | 0.7097 | Low High |
|||||
Day Low | 0.6603 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Vaxart Inc | VXRT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.6985 | 0.6603 | 0.7097 | 0.7097 | 0.6584 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
3,680 | 1,321,643 | US$ 0.6871195 | US$ 908,127 | - | 0.53 - 1.59 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:51:28 | formt | 1,000 | US$ 0.71 | USD |
Vaxart Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
123.44M | 173.86M | - | 7.38M | -82.47M | -0.47 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Vaxart News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VXRT Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.82 | 0.8568 | 0.6331 | 0.7218726 | 1,560,934 | -0.11 | -13.41% |
1 Month | 1.33 | 1.34 | 0.6331 | 0.9709773 | 1,657,447 | -0.62 | -46.62% |
3 Months | 1.20 | 1.54 | 0.6331 | 1.15 | 1,721,431 | -0.49 | -40.83% |
6 Months | 0.6341 | 1.54 | 0.53 | 0.9854986 | 1,510,529 | 0.0759 | 11.97% |
1 Year | 0.73 | 1.59 | 0.53 | 0.9514277 | 1,555,231 | -0.02 | -2.74% |
3 Years | 5.68 | 11.108 | 0.53 | 5.76 | 4,002,974 | -4.97 | -87.50% |
5 Years | 0.6816 | 24.90 | 0.2543 | 6.72 | 6,435,825 | 0.0284 | 4.17% |
Vaxart Description
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States. |